Acute Myeloid Leukemia - Epidemiology Forecast to 2029

2020-06-29
Price :
Published : Jun-2020
No. of Pages : 37
Table of Contents
1.1 List of Tables
1.2 List of Figures
2 AML: Executive Summary
2.1 Catalyst
2.2 Related Reports
2.3 Upcoming Reports
3 Epidemiology
3.1 Disease Background
3.2 Risk Factors and Comorbidities
3.3 Global and Historical Trends
3.4 Forecast Methodology
3.4.1 Sources Used and Not Used
3.4.2 Forecast Assumptions and Methods
3.5 Epidemiological Forecast for AML (2019-2029)
3.5.1 Diagnosed Incident Cases of AML
3.5.2 Age-Specific Diagnosed Incident Cases of AML
3.5.3 Sex-Specific Diagnosed Incident Cases of AML
3.5.4 Diagnosed Incident Cases of AML by Risk Group
3.5.5 Diagnosed Incident Cases of Secondary AML
3.5.6 Diagnosed Incident Cases of APL
3.5.7 Five-Year Diagnosed Prevalent Cases of AML
3.6 Discussion
3.6.1 Epidemiological Forecast Insight
3.6.2 Coronavirus Disease 2019 (COVID-19) Impact
3.6.3 Limitations of Analysis
3.6.4 Strengths of Analysis
4 Appendix
4.1 Bibliography
4.2 About the Authors
4.2.1 Epidemiologist
4.2.2 Reviewers
4.2.3 Global Director of Therapy Analysis and Epidemiology
4.2.4 Global Head and EVP of Healthcare Operations and Strategy
4.3 About GlobalData
4.4 Contact Us
4.5 Disclaimer

List of Tables
Table 1: Summary of Newly Added Data Types and Countries
Table 2: Summary of Updated Data Types
Table 3: Risk Factors for AML

List of Figures
Figure 1: 8MM, Diagnosed Incident Cases of AML, Men and Women, Ages 18 Years and Older, 2019 and 2029
Figure 2: 8MM, Five-Year Diagnosed Prevalent Cases of AML, Men and Women, Ages 18 Years and Older, 2019 and 2029
Figure 3: 8MM, Diagnosed Incidence of AML, Men and Women, Ages 18 Years and Older, 2009-2019
Figure 4: Sources Used to Forecast the Diagnosed Incident Cases of AML
Figure 5: Sources Used to Forecast the Diagnosed Incident Cases of AML by Risk Group
Figure 6: Sources Used to Forecast the Diagnosed Incident Cases of Secondary AML
Figure 7: Sources Used to Forecast the Diagnosed Incident Cases of APL
Figure 8: Sources Used to Forecast the Five-Year Diagnosed Prevalent Cases of AML
Figure 9: 8MM, Diagnosed Incident Cases of AML, Men and Women, Ages ?18 Years, 2019
Figure 10: 8MM, Diagnosed Incident Cases of AML by Age Group, Men and Women, 2019
Figure 11: 8MM, Diagnosed Incident Cases of AML by Sex, Ages ?18 Years, 2019
Figure 12: 8MM, Diagnosed Incident Cases of AML by Risk Group, Men and Women, Ages ?18 Years, 2019
Figure 13: 8MM, Diagnosed Incident Cases of Secondary AML, Men and Women, Ages ?18 Years, 2019
Figure 14: Diagnosed Incident Cases of APL, 8MM, Men and Women, Ages ?18 Years, 2019 and 2029
Figure 15: 8MM, Five-Year Diagnosed Prevalent Cases of AML, Men and Women, Ages ?18 Years, 2019
Filed in: Pharmaceutical
Publisher : GlobalData